Related Experiment Video
Updated: Sep 19, 2025

Subcostal Specimen Removal in Completely Portal Robotic Lobectomy
Published on: April 19, 2024
Margin analysis of radical tonsillectomy specimens following transoral robotic surgery
Jane Y Tong1, Kathryn Brimanson2, Kelly Moyer1
1Department of Otorhinolaryngology - Head and Neck Surgery, University of Maryland, School of Medicine, Baltimore, MD, United States.
Objectives:
Interpretation of margin adequacy in patients with squamous cell carcinoma (SCC) of the palatine tonsil treated with transoral robotic surgery (TORS) remains controversial and variable in practice. We describe margin analysis after radical tonsillectomy, including muscle invasion and surgical disruption.
Methods:
Patients undergoing TORS radical tonsillectomy between January 2017 to December 2023 were retrospectively reviewed. Pathology reports were reviewed for positive, close (<2 mm), or clear margins. Slides were evaluated for likely iatrogenic disruption of the pharyngeal constrictor, defined as the separation of muscle fibers with cautery artifact and evidence of margin ink seepage, as well as for muscle invasion, stratified as absent, partial (within muscle) or complete (beyond muscle).
Results:
Sixty-six patients with SCC of the palatine tonsil underwent TORS radical tonsillectomy. Fifty-seven (86.4 %) were male. Mean age was 59.7 years. Thirty-one (47.0 %) were pT1, 32 (48.5 %) pT2, and three (4.5 %) pT3. Thirty-six (54.5 %) demonstrated close, 26 (39.4 %) clear, and four (6.1 %) positive margins. All demonstrated muscle disruption. Twenty-seven (40.9 %) demonstrated no muscle invasion, 32 (48.5 %) partial, and seven (10.6 %) complete invasion. Margin status was not significantly associated with muscle invasion. Muscle invasion was associated with T stage (p = 0.049), number of involved lymph nodes (p = 0.043), and adjuvant treatment (p = 0.016). Margin status was significantly associated with PNI (p < 0.001).
Conclusions:
Surgical muscle disruption was universal during radical tonsillectomy. Muscle invasion (59.1 %) and close margins (54.5 %) also were common. Muscle invasion was associated with T stage, number of involved lymph nodes, and adjuvant treatment, but not margin status, although this requires further study. Clear margins traditionally defined as ≥ 5 mm may not be anatomically feasible for palatine tonsil malignancies.
Insights
Surgical muscle disruption is common in transoral robotic surgery (TORS) for squamous cell carcinoma (SCC) of the palatine tonsil. Muscle invasion, not margin status, correlated with advanced T stage and lymph node involvement.
Area of Science:
- Otolaryngology
- Surgical Oncology
- Pathology
Background:
- Margin assessment in transoral robotic surgery (TORS) for palatine tonsil squamous cell carcinoma (SCC) is complex.
- Variability exists in interpreting margin adequacy due to surgical factors like muscle invasion and disruption.
Purpose of the Study:
- To analyze margin status, muscle invasion, and surgical disruption in patients with palatine tonsil SCC treated with TORS.
- To investigate associations between margin status, muscle invasion, and clinicopathological factors.
Main Methods:
- Retrospective review of 66 patients with palatine tonsil SCC undergoing TORS radical tonsillectomy (2017-2023).
- Pathology reports analyzed for margin status (positive, close <2mm, clear).
- Slides evaluated for iatrogenic muscle disruption and muscle invasion (absent, partial, complete).
Main Results:
- All patients (100%) showed surgical muscle disruption.
- Muscle invasion occurred in 59.1% of cases; close margins in 54.5%.
- Muscle invasion correlated with T stage, lymph node count, and adjuvant treatment (p<0.05), but not margin status. Margin status correlated with perineural invasion (PNI) (p<0.001).
Conclusions:
- Surgical muscle disruption is a universal finding in TORS tonsillectomy for SCC.
- Muscle invasion and close margins are frequent, with invasion linked to disease severity.
- Traditional clear margin definitions (≥5mm) may be anatomically challenging for palatine tonsil tumors, necessitating further research.

